Anton P. Porsteinsson

Dr. Anton P. Porsteinsson is a Professor of Psychiatry at the University of Rochester School of Medicine and Dentistry, with joint appointments in Neurology, Medicine (Geriatrics), and Neuroscience. As Director of the Alzheimer's Disease Care, Research and Education Program (AD-CARE) and William B. and Sheila Konar Professor of Psychiatry, his work focuses on Alzheimer's disease and dementia through clinical research, biomarker discovery, and pharmacotherapeutic development.

• MD from University of Iceland School of Medicine (1987)
• Psychiatry residency at University of Rochester (1990-1993)
• Board certified in Psychiatry and Geriatric Psychiatry

His research spans Alzheimer's disease, neuropsychiatric symptoms, neuroimaging, and clinical trial design. Recent publications examine agitation management, tau pathology, digital health monitoring, and genetic risk factors. He has led major trials with aducanumab, escitalopram, and semorinemab.

Over 25+ years, Dr. Porsteinsson has received 12 awards including America's Top Doctors (2012), Dr. John Baum Award (2009), and Thorvaldur Thoroddsens Memorial Award (1981). As site PI for NIH grants, he investigates biomarkers, neurodegeneration, and cognitive preservation strategies.

• Board-certified in Psychiatry & Geriatric Psychiatry
• Director of AD-CARE program
• Author of 100+ Alzheimer's publications
• Principal investigator in multiple phase 3 trials
• International expert in dementia pharmacology